|
1) Apartis E, Leger JM, Musset L, et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection？ J Neurol Neurosurg Psychiatry. 1996; 60: 661-6
|
|
|
|
2) Authier FJ, Bassez G, Payan C, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology. 2003; 60: 808-12
|
|
|
|
|
|
3) Tembl JI, Ferrer JM, Sevilla MT, et al. Neurologic complications associated with hepatitis C virus infection. Neurology. 2000; 55: 459
|
|
|
|
|
|
4) Ijichi T, Kono I, Mori S, et al. Peripheral neuropathy in Japanese patients with hepatitis C virus infection. Intern Med. 2003; 42: 394-9
|
|
|
|
|
5) Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol. 2001; 28: 109-18
|
|
|
|
|
|
6) Boukhris S, Magy L, Senga-mokono U, et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol. 2006; 13: 937-41
|
|
|
|
|
7) Souayah N, Sander HW, Menkes DL, et al, Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide. Neurol Neurophysiol Neurosci. 2006; 18: 5
|
|
|
|
|
|
8) De Martino L, Sampaolo S, Tucci C, et al. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve. 2003; 27: 102-4
|
|
|
|
|
|
9) Saadoun D, Bieche I, Maisonobe T, et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum. 2005; 52: 2917-25
|
|
|
|
|
|
10) Bryce AH, Kyle RA, Dispenzieri A, et al. Natural history and therapy of 66 patients with mixed cryoglobulinemia. Am J Hematol. 2006; 81: 511-8
|
|
|
|
|
|
11) Levy Y, Uziel Y, Zandman GG, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003; 62: 1221-3
|
|
|
|
|
|
12) Mazzaro C, Zorat F, Caizzi M, et al. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol. 2005; 42: 632- 8
|
|
|
|
|
|
13) Cacoub P, Saadoun D, Limal N, et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2005; 52: 911-5
|
|
|
|
|
|
14) Saadoun D, Resche-Rigon M, Thibault V, et al. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum. 2006; 54: 3696-706
|
|
|
|
|
|
15) Koskinas J, Kilidireas C, Karandreas N, et al. Severe hepatitis C virus-related cryoglobulinaemic sensory-motor polyneuropathy treated with pegylated interferon-a2b and ribavirin: clinical, laboratory and neurophysiological study. Liver Int. 2007; 27: 414-20
|
|
|
|
|
|
16) Beuthien W, Mellinghoff HU, Kempis J. Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature. Clin Rheumatol. 2005; 24: 507-15
|
|
|
|
|
|
17) Stefanutti C, Di Giacomo S, Mareri M, et al. Immunoadsorption apheresis (Selesorb) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia. Transfus Apher Sci. 2003; 28: 207-14
|
|
|
|
|
|
18) Yaghi C, Baz P, Koussa S, et al. Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C. Gastroenterol Clin Biol. 2005; 29: 616-7
|
|
|
|
|
|
19) Willson RA. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection. J Clin Gastroenterol. 2004; 38: 717-22. Review
|
|
|
|
|
|
20) Vardizer Y, Linhart Y, Loewenstein A, et al. Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy. J Neuroophthalmol. 2003; 23: 256-9
|
|
|
|
|
|
21) Gemignani F, Brindani F, Alfieri S, et al. Clinical spectrum of cryoglobulinaemic neuropathy. J Neurol Neurosurg Psychiatry. 2005; 76: 1410-4
|
|
|
|
|
|
22) Beuthien W, Mellinghoff HU, Kempis J. Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature. Clin Rheumatol. 2005; 24: 507-15
|
|
|
|
|
|
23) Briani C, Chemello L, Zara G, et al. Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. Neurology. 2007: 68(18): 1543-4
|
|
|
|
|
|
24) Sansonno D, De Re V, Lauletta G, et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood. 2003; 101: 3818-26
|
|
|
|
|
|
25) Cai FZ, Ahern M, Smith M. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol. 2006; 33: 1197-8
|
|
|
|
|
|
26) Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003; 101: 3827-34
|
|
|
|
|